NCT02171260 · Interventional trial
This is a Phase 1 Study of Eribulin Mesylate in Pediatric Participants With Recurrent or Refractory Solid Tumors (Excluding [Central Nervous System] CNS), Including Lymphomas
Overall registry status Completed
Phase 1
Conditions Pediatrics, Solid Tumors
Delaware Valley sites
- Childrens Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory